... of the impairment of the NOS pathway. 14 01 2011 28 03 2011 3 6 2011 Antihypertensive Aorta, blood pressure Heme oxygenase Heme oxygenase inhibitors Hypertension NG-nitro- L -arginine methyl ester Nitric oxide synthase Renal hypertension Original Paper Pharmacology 2011;87:341 349...

... (0.5 and 1.0 g/100 g food) attenuated the rate of elevation of blood pressure, but failed to maintain systolic blood pressures at levels significantly below that of untreated renal hypertensive controls. The body weight of the rats was not affected significantly by treatment with any dose of tryptophan...

.... Renal hypertension Tyrosine Drinking Food intake Tail skin temperature Vascular reactivity Phenylephrine Isoproterenol Pharmacology 31: 132-149 (1985) Effect of l-p-Tyrosine on the Development of Renal Hypertension in Rats Ora E. Lockley, Melvin J. Fregly, Dennis C. Eater Department...

...Rose M. Threatte; Melvin J. Fregly; Peter Field Renal hypertension in rats was accompanied by both a decrease in thyroid activity (i.e., decreased total serum triiodothyronine concentration, increased serum thyroid-stimulating hormone concentration and increased thyroid weight) and renal function...

...Ruben D. Buñag One-kidney renal hypertension was induced in rats that had been given Enovid or corn oil by daily gavage for 5 weeks, and treatment was then continued postoperatively for 10 weeks more. Systolic pressures began to rise almost immediately after hypertension was induced, and from...

.../NaCl Renal hypertension Hypotensives Sympathetic NS Pharmacology 5: 245-254 (1971) The Neurogenic Component in the Experimental Hypertensive Rat L. F inch School of Studies in Pharmacology, University of Bradford, Bradford Abstract. Experiments were carried out to determine the Key Words role...

... to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Nitric oxide Endothelium-derived hyperpolarizing factor Endothelium K + channels Renal hypertension Original Paper Pharmacology 2004;72:231 239 DOI: 10.1159/000080378...